Member Login
  1. Tag
    2. /
  2. GlaxoSmithKline
    3. /

GlaxoSmithKline

Top Articles

Young mixed-race woman jumping for joy in a park with confetti falling around her
Investing Articles

9 stocks that Fools have been buying!

| The Motley Fool Staff

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Illustration of flames over a black background
Investing Articles

Just released: April’s higher-risk, high-reward stock recommendation [PREMIUM PICKS]

| Mark Rogers

Fire ideas will tend to be more adventurous and are designed for investors who can stomach a bit more volatility.

Read more »

Young Black woman looking concerned while in front of her laptop
Investing Articles

5 stocks that Fools think are overvalued

| The Motley Fool Staff

There are a few famous value investors who spring to mind that might take one look at these stocks, and…

Read more »

Black father and two young daughters dancing at home
Investing Articles

Just released: our 3 top small-cap stocks to buy before May [PREMIUM PICKS]

| Mark Rogers

Small-cap shares tend to be more volatile than larger companies, so we suggest investors should look to build up a…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

“The last FTSE 100 stock I’d sell in a recession is…”

| The Motley Fool Staff

It's well worth considering some recession-resiliant stocks as part of a diversifed portfolio. Here, our free-site writers offer up their…

Read more »

Number three written on white chat bubble on blue background
Investing Articles

Just released: the 3 best growth-focused stocks to buy in April [PREMIUM PICKS]

| Mark Rogers

Our goal here is to highlight some of our past recommendations that we think are of particular interest today, due…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

“The last holding I’d want to sell in my Stocks and Shares ISA is…”

| The Motley Fool Staff

Happy New Tax Year, to all Stocks and Shares ISA owners! The £20,000 allowance has reset -- will you be…

Read more »

Investing Articles

Recently released: our latest Hidden Winners ‘sell’ recommendation [PREMIUM PICKS]

| Mark Rogers

Here at The Motley Fool, we don’t hide the fact that ‘selling’ is part of the investment equation.

Read more »

Recent GlaxoSmithKline News

Investing Articles

Why I’d buy 6% yielder GlaxoSmithKline plc for my ISA after this news

| Roland Head

A new deal has lifted the GlaxoSmithKline plc (LON:GSK) share price. Roland Head explains why he'd rate the stock as…

Read more »

Investing Articles

GlaxoSmithKline plc isn’t the only pharma stock worth investing in for retirement

| Peter Stephens

This company could generate high returns alongside GlaxoSmithKline plc (LON:GSK) (GSK.L).

Read more »

Investing Articles

Is Footsie dividend stalwart GlaxoSmithKline plc’s dividend under threat?

| Paul Summers

Here's why recent positive numbers from pharma giant GlaxoSmithKline plc (LON:GSK) may not be enough to prevent it from cutting…

Read more »

Investing Articles

Why I’d buy and hold dividend stocks GlaxoSmithKline plc & Taylor Wimpey plc

| Alan Oscroft

GlaxoSmithKline plc (LON: GSK) and Taylor Wimpey plc (LON: TW) could be among the best dividend payers of the next…

Read more »

Investing Articles

Are GlaxoSmithKline plc shares a bargain after FY2017 results?

| Edward Sheldon, CFA

GlaxoSmithKline plc (LON: GSK) currently yields 6.1% and trades on a P/E of 11.8. Does that make the shares a…

Read more »

Investing Articles

Why I’d avoid this 4.5% dividend yielder and buy GlaxoSmithKline plc instead

| Kevin Godbold

This 4.5% dividend yielder may look attractive, but here’s why my money would go on GlaxoSmithKline plc (LON: GSK)

Read more »

Investing Articles

One 5% yielder I’d consider over GlaxoSmithKline plc

| Jack Tang

Are you considering alternative dividend picks amid an earnings plateau at GlaxoSmithKline plc (LON:GSK)?

Read more »

Investing Articles

GlaxoSmithKline plc isn’t the only Footsie dividend stock I’d buy today

| Royston Wild

Royston Wild explains why GlaxoSmithKline (LON: GSK) isn't the only income star that could make you a fortune.

Read more »

Investing Articles

GlaxoSmithKline plc isn’t the only unloved dividend stock I’d buy and hold forever

| Roland Head

Roland Head explains why now could be the time to start buying GlaxoSmithKline plc (LON:GSK).

Read more »

Investing Articles

Why I believe you can double your money with Footsie champion GlaxoSmithKline plc

| Rupert Hargreaves

GlaxoSmithKline plc (LON: GSK) could help you double your money in 2018.

Read more »

Investing Articles

Why GlaxoSmithKline plc shares could be the buy of the decade

| G A Chester

After a challenging few years, the fortunes of GlaxoSmithKline plc (LON:GSK) could be set for a dramatic improvement.

Read more »

Investing Articles

Should I swap GlaxoSmithKline plc for this turnaround stock?

| Peter Stephens

Could this company offer higher returns than GlaxoSmithKline plc (LON:GSK)?

Read more »

Investing Articles

This promising small-cap stock could be a millionaire maker in 2018

| Paul Summers

For those willing to take the risk, Paul Summers thinks there could be substantial upside ahead for backers of this…

Read more »

Investing Articles

How to make a million WITHOUT buying ‘sin stocks’

| Bilaal Mohamed

Bilaal Mohamed explains how ethical investing can still be a very profitable way to build wealth.

Read more »

Investing Articles

Why I would buy out-of-favour Bunzl plc over GlaxoSmithKline plc

| Harvey Jones

Harvey Jones reckons Bunzl plc (LON: BNZL) could fly back into favour before fellow struggler GlaxoSmithKline plc (LON: GSK).

Read more »

Investing Articles

Which is the better dividend stock: Royal Dutch Shell plc or GlaxoSmithKline plc?

| Edward Sheldon, CFA

Royal Dutch Shell plc (LON: RDSB) and GlaxoSmithKline plc (LON: GSK) are two of the most popular dividend stocks, but…

Read more »

Investing Articles

One dividend dud I’d sell to buy GlaxoSmithKline plc

| Royston Wild

Royston Wild explains why GlaxoSmithKline plc (LON: GSK) is on course to deliver stunning shareholder returns.

Read more »

Investing Articles

This FTSE 100-beating investment trust could be a better buy than GlaxoSmithKline plc

| Roland Head

Roland Head suggests a long-term alternative to FTSE 100 (INDEXFTSE:UKX) pharma giant GlaxoSmithKline plc (LON:GSK).

Read more »

Investing Articles

Why GlaxoSmithKline plc is my FTSE 100 stock pick for the next decade

| Alan Oscroft

The FTSE 100 (INDEXFTSE:UKX) is still probably the best index for long-term investors, and GlaxoSmithKline plc (LON: GSK) could be…

Read more »

Investing Articles

Is GlaxoSmithKline plc’s 6% dividend yield safe?

| Rupert Hargreaves

The market seems to be suggesting that GlaxoSmithKline plc's (LON: GSK) dividend will be cut.

Read more »

Investing Articles

Why GlaxoSmithKline plc is a growth bargain I’d buy and hold for 25 years

| Peter Stephens

GlaxoSmithKline plc (LON: GSK) could be one of the best investment opportunities in the FTSE 100.

Read more »

Investing Articles

Is GlaxoSmithKline plc still a strong buy after Q3 results?

| Bilaal Mohamed

Bilaal Mohamed shares his views on today's third-quarter results from GlaxoSmithKline plc (LON:GSK).

Read more »

Investing Articles

GlaxoSmithKline plc is one of 10 top stocks for a Footsie starter portfolio

| G A Chester

G A Chester's quarterly review of 10 FTSE 100 (INDEXFTSE:UKX) industry giants, including GlaxoSmithKline plc (LON:GSK).

Read more »

Investing Articles

Why I’d buy GlaxoSmithKline plc for its 5%+ dividend yield today

| Edward Sheldon, CFA

Edward Sheldon explains why he sees appeal in GlaxoSmithKline plc's (LON:GSK) 5.4% dividend yield.

Read more »

Investing Articles

Why I’d buy this biotechnology star alongside GlaxoSmithKline plc

| Alan Oscroft

This great growth prospect should nicely complement solid dividends from GlaxoSmithKline plc (LON: GSK).

Read more »

Investing Articles

One long-term growth stock I’d buy alongside GlaxoSmithKline plc

| Royston Wild

Royston Wild explains why GlaxoSmithKline plc (LON: GSK) isn’t the only great growth stock out there.

Read more »

Investing Articles

This four-bagger should continue to thrash GlaxoSmithKline plc

| Harvey Jones

Harvey Jones says that ailing pharmaceuticals giant GlaxoSmithKline plc (LON: GSK) looks even more sluggish when set against this healthcare…

Read more »

Investing Articles

An exciting pharma stock to consider alongside GlaxoSmithKline plc

| Kevin Godbold

GlaxoSmithKline plc (LON: GSK) would make a great pairing with this potential blockbuster growth firm.

Read more »

Investing Articles

Why I’ve sold this turnaround stock to buy GlaxoSmithKline plc

| Peter Stephens

GlaxoSmithKline plc (LON: GSK) seems to have a better risk/reward ratio than this struggling business.

Read more »

Investing Articles

Is Neil Woodford wrong about British American Tobacco plc and GlaxoSmithKline plc?

| Rupert Hargreaves

Should you follow Neil Woodford and sell GlaxoSmithKline plc (LON: GSK) and British American Tobacco plc (LON: BATS)?

Read more »

Investing Articles

GlaxoSmithKline plc or Imperial Brands plc: which FTSE 100 favourite will be first to slash its dividend?

| Paul Summers

Reliant on GlaxoSmithKline plc (LON:GSK) or Imperial Brands plc (LON:IMB) for income? You need to read this.

Read more »

Investing Articles

Hikma Pharmaceuticals plc’s pain could be GlaxoSmithKline plc’s gain

| Zach Coffell

Could ongoing approval issues at Hikma Pharmaceuticals plc (LON: HIK) and rivals help GlaxoSmithKline plc (LON:GSK) preserve its dividend?

Read more »

Investing Articles

Why I think Woodford was right to dump GlaxoSmithKline plc

| Roland Head

Roland Head gives his verdict on the latest figures from GlaxoSmithKline plc (LON:GSK).

Read more »

Investing Articles

Should you follow Neil Woodford and dump GlaxoSmithKline plc?

| Rupert Hargreaves

Is it time to sell GlaxoSmithKline plc (LON: GSK)?

Read more »

Investing Articles

Neil Woodford has just bought Lloyds Banking Group plc and sold GlaxoSmithKline plc

| G A Chester

Here's why Neil Woodford has backed Lloyds Banking Group plc (LON:LLOY) and dumped GlaxoSmithKline plc (LON:GSK).

Read more »

Investing Articles

Are these bombed-out pharma stocks worth buying?

| Rupert Hargreaves

Should you catch these falling knives?

Read more »

Investing Articles

3 powerful reasons to desire GlaxoSmithKline plc right now

| Bilaal Mohamed

Bilaal Mohamed gives investors three good reasons to consider high-yielding pharmaceuticals giant GlaxoSmithKline plc (LON:GSK).

Read more »

Investing Articles

Last chance to buy GlaxoSmithKline plc for under £16?

| G A Chester

Is now the perfect time to buy a stake in GlaxoSmithKline plc (LON:GSK)?

Read more »

Investing Articles

2 FTSE 100 dividend stocks for beginners

| Rupert Hargreaves

If you don't know where to start, these dividend stocks can help you build your portfolio from scratch.

Read more »

Investing Articles

This fast-growing pharmaceutical stock blows GlaxoSmithKline plc out of the water

| Harvey Jones

These two different stocks in the same sector strike a happy balance, says Harvey Jones.

Read more »